Towards a validation of the standard and enzyme-linked comet assay: a retrospective variability analysis
Archives of Toxicology
Maria Dusinska har 130 publikasjoner ved NILU
Preventing regrettable substitutions: a proposal for a tiered testing approach for BPA alternatives under the PARC initiative
Frontiers in Toxicology
A regulatory perspective on the applicability of NAMs in genotoxicity and carcinogenicity assessment in EU: current practices and future directions
Environment International
Thermodynamic and electron paramagnetic resonance descriptors of TiO2 nanoforms interaction with plasma albumin: The interplay between energetic parameters and nanomaterial's toxicity
Colloids and Surfaces B: Biointerfaces
Hazard and Life Cycle Assessment of Safe and Sustainable Coatings
22nd Global Conference on Sustainable Manufacturing
DNA damage in oral mucosal epithelial cells cultured in complex and xenobiotic-free media: a comparison study
Mutagenesis
Testing ethical impact assessment for nano risk governance
Open Research Europe
Risk Assessment in Nanomedicine. Needs for harmonisation, standardisation and validation
Nano to Clinic – Synergies for Clinical Translation of Nanotechnology in Cancer Therapies
New approach methodologies to facilitate and improve the hazard assessment of non-genotoxic carcinogens—a PARC project
Frontiers in Toxicology
New approaches to hazard and risk assessment of nanomaterials. RiskGONE perspective.
International Conference on New Achievements in Science, Technology and Arts (ICNA-STA)
CeO2 Nanoparticles-assisted stem-based cell therapy: an innovative nanopharmaceutical approach to treat retinal degenerative diseases (CELLUX)
Målet for prosjektet CELLUX er å utvikle en ny type øyedråper for behandling av aldersrelatert nedbrytning av makula (del av netthinna) (Age Macular Degeneration, AMD), basert på CeO2 nanopartikler som […]
Science-based risk governance of nanotechnology (RiskGone)
NILU leder et internasjonalt konsortium om risikostyring for konstruerte nanomaterialer i H2020-prosjektet RiskGONE. I tillegg til den koordinerende rollen er NILU ansvarlig for å sette opp retningslinjer for risiko-/nyttevurdering av […]
Towards a reliable assessment of nanomaterial health effects using advanced biological models and assays (NanoBioReal)
Det er behov for å fremskaffe et godt vitenskapelig grunnlag for å beregne risiko for de som er eksponert til nanomaterialer (NMs), for å informere regulatoriske myndigheter samt å sikre […]
Maria Dusinska har 130 publikasjoner ved NILU
Towards a validation of the standard and enzyme-linked comet assay: a retrospective variability analysis
Archives of Toxicology
Preventing regrettable substitutions: a proposal for a tiered testing approach for BPA alternatives under the PARC initiative
Frontiers in Toxicology
A regulatory perspective on the applicability of NAMs in genotoxicity and carcinogenicity assessment in EU: current practices and future directions
Environment International
Thermodynamic and electron paramagnetic resonance descriptors of TiO2 nanoforms interaction with plasma albumin: The interplay between energetic parameters and nanomaterial's toxicity
Colloids and Surfaces B: Biointerfaces
Hazard and Life Cycle Assessment of Safe and Sustainable Coatings
22nd Global Conference on Sustainable Manufacturing
DNA damage in oral mucosal epithelial cells cultured in complex and xenobiotic-free media: a comparison study
Mutagenesis
Testing ethical impact assessment for nano risk governance
Open Research Europe
Risk Assessment in Nanomedicine. Needs for harmonisation, standardisation and validation
Nano to Clinic – Synergies for Clinical Translation of Nanotechnology in Cancer Therapies
New approach methodologies to facilitate and improve the hazard assessment of non-genotoxic carcinogens—a PARC project
Frontiers in Toxicology
New approaches to hazard and risk assessment of nanomaterials. RiskGONE perspective.
International Conference on New Achievements in Science, Technology and Arts (ICNA-STA)
CeO2 Nanoparticles-assisted stem-based cell therapy: an innovative nanopharmaceutical approach to treat retinal degenerative diseases (CELLUX)
Målet for prosjektet CELLUX er å utvikle en ny type øyedråper for behandling av aldersrelatert nedbrytning av makula (del av netthinna) (Age Macular Degeneration, AMD), basert på CeO2 nanopartikler som […]
Science-based risk governance of nanotechnology (RiskGone)
NILU leder et internasjonalt konsortium om risikostyring for konstruerte nanomaterialer i H2020-prosjektet RiskGONE. I tillegg til den koordinerende rollen er NILU ansvarlig for å sette opp retningslinjer for risiko-/nyttevurdering av […]
Towards a reliable assessment of nanomaterial health effects using advanced biological models and assays (NanoBioReal)
Det er behov for å fremskaffe et godt vitenskapelig grunnlag for å beregne risiko for de som er eksponert til nanomaterialer (NMs), for å informere regulatoriske myndigheter samt å sikre […]